A detailed history of Signaturefd, LLC transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 30 shares of SLP stock, worth $862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$862
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

SELL
$36.55 - $51.15 $3,070 - $4,296
-84 Reduced 73.68%
30 $1,000
Q3 2022

Nov 08, 2022

BUY
$47.75 - $66.88 $1,098 - $1,538
23 Added 25.27%
114 $6,000
Q2 2022

Aug 10, 2022

BUY
$40.55 - $51.76 $1,257 - $1,604
31 Added 51.67%
91 $4,000
Q1 2022

May 02, 2022

BUY
$36.56 - $50.98 $1,096 - $1,529
30 Added 100.0%
60 $3,000
Q4 2021

Jan 25, 2022

SELL
$37.1 - $57.45 $667 - $1,034
-18 Reduced 37.5%
30 $1,000
Q3 2021

Oct 28, 2021

BUY
$38.45 - $55.66 $692 - $1,001
18 Added 60.0%
48 $2,000
Q2 2021

Jul 26, 2021

SELL
$49.67 - $68.96 $3,278 - $4,551
-66 Reduced 68.75%
30 $2,000
Q1 2021

Apr 30, 2021

BUY
$60.06 - $89.52 $3,183 - $4,744
53 Added 123.26%
96 $6,000
Q4 2020

Feb 11, 2021

SELL
$53.26 - $77.18 $1,384 - $2,006
-26 Reduced 37.68%
43 $3,000
Q3 2020

Nov 03, 2020

BUY
$57.51 - $75.36 $1,495 - $1,959
26 Added 60.47%
69 $5,000
Q2 2020

Jul 30, 2020

BUY
$32.91 - $59.82 $131 - $239
4 Added 10.26%
43 $3,000
Q1 2020

Apr 23, 2020

BUY
$26.79 - $38.99 $107 - $155
4 Added 11.43%
39 $1,000
Q3 2019

Oct 16, 2019

SELL
$28.19 - $41.75 $451 - $668
-16 Reduced 31.37%
35 $1,000
Q1 2019

May 09, 2019

SELL
$18.84 - $21.36 $56 - $64
-3 Reduced 5.56%
51 $1,000
Q4 2018

Feb 13, 2019

BUY
$17.56 - $21.2 $263 - $318
15 Added 38.46%
54 $1,000
Q1 2018

May 08, 2018

BUY
$14.4 - $16.8 $561 - $655
39 New
39 $1,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $584M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.